← Open Payments lookup

LEEANNE VANDEGRIFF: Open Payments

NPI 1760074470 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,806 in 81 payments from 39 companies in 2025. Trend: 2023 $2,052 · 2024 $2,547 · 2025 $2,806

Food & beverage: $2,806
CompanyPaymentsAmount
Daiichi Sankyo Inc.9$284
Janssen Biotech, Inc.4$262
Gilead Sciences, Inc.3$165
Sirtex Medical Inc2$161
AstraZeneca Pharmaceuticals LP7$158
Genmab U.S., Inc.2$146
Geron Corporation3$131
Stemline Therapeutics Inc.2$124
PUMA BIOTECHNOLOGY, INC.1$121
ADC THERAPEUTICS AMERICA, INC.1$113

Products named: SIR-Spheres Microspheres, RYTELO, Tivdak, Orserdu, NERLYNX, RYBREVANT, ZYNLONTA, Vanflyta.

Industry payments across TX — which companies pay providers there.